Ramius Advisors’s Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 NFYS.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-30,000
Closed -$3K 207
2022
Q3
$3K Buy
+30,000
New +$3.72K ﹤0.01% 202

Other funds holding NFYS.WS

Ramius Advisors's NFYS.WS Position: Q4 2022 in Review

Ramius Advisors sold out of Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFYS.WS) in Q4 2022, closing a stake of 30,000 shares — an estimated $3K sold.

Ramius Advisors first reported a position in NFYS.WS in Q3 2022 and held it in 1 quarter. The position peaked at $3K in Q3 2022. 33 funds tracked by Wall St. Rank hold NFYS.WS as of Q4 2022.

  • Ramius Advisors reported no remaining Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • Ramius Advisors sold 30,000 Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2022, an estimated $3K.
  • Ramius Advisors first reported a position in Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q3 2022 and held it in 1 quarter.
  • Ramius Advisors's Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $3K in Q3 2022.
  • 33 funds tracked by Wall St. Rank held Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2022.

Based on Ramius Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.